💳Personal FinanceNovo Nordisk Shares Slip as Drugmaker Highlights Bone Protection Data and Pediatric Weight Loss
Novo Nordisk shares fell 2.94% to $40.37 following new clinical data regarding its obesity treatments, including bone health biomarkers for CagriSema and pediatric BMI re…